Clinical Trial

Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance

Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to fill this essential knowledge gap by assessing the impact of oral cholera vaccine mass campaigns in 2 sites (urban and rural) in DRC, described in this protocol. The evidence generated from this project will be key to develop future strategies regarding cholera vaccine use in endemic settings, including places with higher burden in terms of cholera mortality.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-04-16; most recent amendment 2024-09-11.
Status change: Not Yet Recruiting → Recruiting 2021-05-12
Trial Details
NCT Number NCT04853186
Lead Sponsor Epicentre
Collaborators: Wellcome Trust, Médecins Sans Frontières, France, Ministry of Public Health, Democratic Republic of the Congo, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, Grand Labo de Lubumbashi
Conditions Cholera
Enrollment 6,000 participants
Start Date 2021-05-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-19